Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      M.A. van Dam; O.D. Bijlstra; R.A. Faber; M.I. Warmerdam; M.P. Achiam; L. Boni; R.A. Cahill; M. Chand; M. Diana; S. Gioux; S. Kruijff; J.R. Van der Vorst; R.J. Rosenthal; K. Polom; A.L. Vahrmeijer; J.S.D. Mieog
    • بيانات النشر:
      Elsevier
    • الموضوع:
      2024
    • Collection:
      The University of Milan: Archivio Istituzionale della Ricerca (AIR)
    • نبذة مختصرة :
      Background: Fluorescence-guided surgery (FGS) has emerged as an innovative technique with promising applications in various surgical specialties. However, clinical implementation is hampered by limited availability of evidence-based reference work supporting the translation towards standard-of-care use in surgical practice. Therefore, we developed a consensus statement on current applications of FGS. Methods: During an international FGS course, participants anonymously voted on 36 statements. Consensus was defined as agreement ≥70% with participation grade of ≥80%. All participants of the questionnaire were stratified for user and handling experience within five domains of applicability (lymphatics & lymph node imaging; tissue perfusion; biliary anatomy and urinary tracts; tumor imaging in colorectal, HPB, and endocrine surgery, and quantification and (tumor-) targeted imaging). Results were pooled to determine consensus for each statement within the respective sections based on the degree of agreement. Results: In total 43/52 (81%) course participants were eligible as voting members for consensus, comprising the expert panel (n=12) and trained users (n=31). Consensus was achieved in 17 out of 36 (45%) statements with highest level of agreement for application of FGS in tissue perfusion and biliary/urinary tract visualization (71% and 67%, respectively) and lowest within the tumor imaging section (0%). Conclusions: FGS is currently established for tissue perfusion and vital structure imaging. Lymphatics & lymph node imaging in breast cancer and melanoma are evolving, and tumor tissue imaging holds promise in early-phase trials. Quantification and (tumor-)targeted imaging are advancing toward clinical validation. Additional research is needed for tumor imaging due to a lack of consensus.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/38104355; info:eu-repo/semantics/altIdentifier/wos/WOS:001136387500001; volume:50; issue:2; firstpage:1; lastpage:9; numberofpages:9; journal:EUROPEAN JOURNAL OF SURGICAL ONCOLOGY; https://hdl.handle.net/2434/1025828; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85180301782
    • الرقم المعرف:
      10.1016/j.ejso.2023.107317
    • الدخول الالكتروني :
      https://hdl.handle.net/2434/1025828
      https://doi.org/10.1016/j.ejso.2023.107317
    • Rights:
      info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.74EA437D